Gilead Sciences, Inc. (BMV:GILD)

Gilead Sciences Statistics

Total Valuation

Gilead Sciences has a market cap or net worth of MXN 2.76 trillion. The enterprise value is 3.05 trillion.

Market Cap	2.76T
Enterprise Value	3.05T

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Sep 15, 2025

Share Statistics

Current Share Class	1.24B
Shares Outstanding	n/a
Shares Change (YoY)	+1.02%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	88.34%
Float	1.24B

Valuation Ratios

The trailing PE ratio is 18.56 and the forward PE ratio is 13.88.

PE Ratio	18.56
Forward PE	13.88
PS Ratio	5.18
PB Ratio	7.02
P/TBV Ratio	n/a
P/FCF Ratio	16.43
P/OCF Ratio	15.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.62, with an EV/FCF ratio of 18.14.

EV / Earnings	20.49
EV / Sales	5.65
EV / EBITDA	11.62
EV / EBIT	14.66
EV / FCF	18.14

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 1.15.

Current Ratio	1.53
Quick Ratio	1.17
Debt / Equity	1.15
Debt / EBITDA	1.75
Debt / FCF	2.70
Interest Coverage	11.00

Financial Efficiency

Return on equity (ROE) is 40.71% and return on invested capital (ROIC) is 15.93%.

Return on Equity (ROE)	40.71%
Return on Assets (ROA)	12.38%
Return on Invested Capital (ROIC)	15.93%
Return on Capital Employed (ROCE)	24.22%
Revenue Per Employee	30.31M
Profits Per Employee	8.45M
Employee Count	17,600
Asset Turnover	0.51
Inventory Turnover	1.98

Taxes

In the past 12 months, Gilead Sciences has paid 32.58 billion in taxes.

Income Tax	32.58B
Effective Tax Rate	17.96%

Stock Price Statistics

The stock price has increased by +28.03% in the last 52 weeks. The beta is 0.35, so Gilead Sciences's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+28.03%
50-Day Moving Average	2,130.00
200-Day Moving Average	1,649.59
Relative Strength Index (RSI)	55.10
Average Volume (20 Days)	1,302

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.27

Income Statement

In the last 12 months, Gilead Sciences had revenue of MXN 533.52 billion and earned 148.76 billion in profits. Earnings per share was 117.81.

Revenue	533.52B
Gross Profit	419.98B
Operating Income	205.41B
Pretax Income	181.33B
Net Income	148.76B
EBITDA	256.15B
EBIT	205.41B
Earnings Per Share (EPS)	117.81

Balance Sheet

The company has 171.57 billion in cash and 454.52 billion in debt, giving a net cash position of -282.95 billion.

Cash & Cash Equivalents	171.57B
Total Debt	454.52B
Net Cash	-282.95B
Net Cash Per Share	n/a
Equity (Book Value)	393.55B
Book Value Per Share	316.87
Working Capital	119.92B

Cash Flow

In the last 12 months, operating cash flow was 177.31 billion and capital expenditures -9.26 billion, giving a free cash flow of 168.05 billion.

Operating Cash Flow	177.31B
Capital Expenditures	-9.26B
Free Cash Flow	168.05B
FCF Per Share	n/a

Margins

Gross margin is 78.72%, with operating and profit margins of 38.50% and 27.88%.

Gross Margin	78.72%
Operating Margin	38.50%
Pretax Margin	33.99%
Profit Margin	27.88%
EBITDA Margin	48.01%
EBIT Margin	38.50%
FCF Margin	31.50%

Dividends & Yields

This stock pays an annual dividend of 60.96, which amounts to a dividend yield of 2.68%.

Dividend Per Share	60.96
Dividend Yield	2.68%
Dividend Growth (YoY)	10.12%
Years of Dividend Growth	1
Payout Ratio	51.74%
Buyback Yield	-1.02%
Shareholder Yield	1.66%
Earnings Yield	5.39%
FCF Yield	6.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 28, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jan 28, 2013
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	7